Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced the appointment of Panmure Gordon (UK) Limited as the Company’s Nominated Adviser and
Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has been awarded contracts worth £2.1 million to provide cognitive assessments,
Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced a positive trading update for the year ended 31 December 2021. Unaudited highlights for
Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has been awarded contracts for two clinical trials by a top 20
Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won a contract worth over £500,000 to provide electronic clinical
Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has secured a contract for an additional schizophrenia clinical trial worth £1.0m.
Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has secured a contract for a further sizeable schizophrenia trial with
Cambridge Cognition’s Matthew Stork discusses interim results, sales order of 74%, Monument Therapeutics, launch of Neurovocalix and what investors can expect over the next 6-12 months in this exclusive interview with DirectorsTalk.
Cambridge Cognition Holdings plc (LON:COG) CEO Matthew Stork joins DirectorsTalk Interviews to discuss interim results for the six months ended 30th June 2021. Matthew talks us through the highlights, explains
Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced its unaudited interim results for the six months ended 30 June 2021. The Company
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
